Patent ID: 7822474
Filing Date: 2010-10-26
Classification: A61N,G01N

Abstract:
1. A method for determining an increased likelihood of the occurrence of a human cardiac arrhythmia, myocardial ischemia, a congestive heart failure and other disease conditions of the human heart comprising: measuring the serum levels of nerve growth factor (NGF) in a human subject; comparing the measured NGF serum level with the normal NGF level to determine whether there is an increase in the serum NGF level; and determining that the human subject has the increased likelihood of the occurrence of the human cardiac arrhythmia, myocardial ischemia, the congestive heart failure and other disease conditions of the human heart when there is a 2.5-fold or greater increase in the serum NGF level, or determining that the human subject does not have an increased likelihood of the occurrence of a human cardiac arrhythmia, myocardial ischemia, a congestive heart failure and other disease conditions of the human heart when there is not the 2.5-fold or greater increase in scrum or plasma NGF level.